Conventional hot CIP operates at 70–85°C. The energy required to heat water to those temperatures — repeated across every circuit, every shift, every year — is a meaningful and often underreported Scope 1 emission source. Moving to ambient or significantly lower temperatures removes that thermal demand entirely. It also eliminates the cool-down phase, which has secondary water and time implications.

🛈 Published Research

PAA is sold commercially as an equilibrium mixture that already contains acetic acid as a formulation component, alongside PAA itself and hydrogen peroxide. When PAA decomposes after application, it produces additional acetic acid as a breakdown product. Acetic acid is an organic compound with significant chemical oxygen demand. When this combines with the organic soil load already mobilized during a CIP clean, the resulting effluent COD can be substantially higher than facilities expect — and is often higher than measurements taken before the sanitizer step.

Ozone’s decomposition pathway produces only oxygen. There is no organic residual, no acetic acid, and no additional COD contribution from the sanitation agent itself. This is confirmed by peer-reviewed literature including Leite et al. (Water Science & Technology, 2021) and Kitis (Environment International, 2004).

We work with trial partners to establish a verifiable baseline — measuring thermal energy per CIP cycle, chemical volume consumed, and chemical origin for Scope 3 calculation. We then measure the same metrics under our process. The delta is calculated using standard GHG Protocol methodology, giving you auditable, independently verifiable figures. These can feed directly into CDP, GRI, or CSRD reporting frameworks. We provide a complete data package as part of any trial engagement.

Yes — and this is central to our value proposition. We do not ask you to trade efficacy for sustainability. Peer-reviewed research has demonstrated that aqueous ozone at appropriate concentration and contact time achieves effective pathogen reduction and biofilm removal at ambient temperatures. One published study (Tirpanci Sivri et al., Frontiers in Microbiology, 2023) found that 10 ppm aqueous ozone for 10 minutes reduced Pseudomonas fluorescens biofilm on pilot-scale equipment below the recovery method’s detection limit. The specific validated performance data for our process — concentration, contact time, kill rate, and substrate type — is shared with partners under NDA, alongside independent laboratory validation.

Yes. The FDA affirmed ozone as Generally Recognized As Safe (GRAS) for direct contact with food under 21 CFR 184.1563. The USDA has approved ozone use in federally inspected meat and poultry facilities. Ozone is also recognized as a Best Available Technique (BAT) for CIP in European food processing reference documents (BREFs). Our trial program is structured to generate data fully aligned with regulatory submission and HACCP documentation requirements.

We begin with a 30-minute discovery call — no technical detail shared at this stage, no obligation. If there’s a potential fit, we execute a mutual NDA and conduct a site assessment to confirm compatibility with your existing CIP infrastructure. Trial installation and commissioning is conducted at our cost. We ask for your team’s time during monitoring, and the opportunity to document outcomes — always subject to your written approval before any external publication. There is no obligation to purchase or commit to any commercial arrangement following the trial.